drugset / Trial / NCT02654314

Prevention of Delirium in Inpatients Utilizing Melatonin

NCT02654314 ↗

Phase 3 Terminated 277 enrolled Yale University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A double blind randomized controlled trial investigating melatonin, 5mg, compared to placebo, given to patients at least 65 years old, admitted to the hospital on a general medical floor, to prevent delirium.

Timeline

Start
2016-07
Primary completion
2017-11-03
Completion
2017-11-03

Outcome

Outcome not reported

Stopped: “Lack of resources to complete the study. Descriptive statistics for the outcome measures collected are provided.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 5 mg —

Indications